Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss

Journal of Biological Chemistry

Volumn 287, Issue 35, 2012, Pages 29851-29860

  Onal, Melda ^a   Xiong, Jinhu ^a   Chen, Xinrong ^a   Thostenson, Jeff D ^b   Almeida, Maria ^a   Manolagas, Stavros C ^a   O'Brien, Charles A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELLS; B LYMPHOCYTES; BONE LOSS; BONE MASS; BONE REMODELING; CANCELLOUS BONE; CELL TYPES; CYTOKINE RECEPTOR; KNOCK OUTS; NUCLEAR FACTORS; PROTEIN EXPRESSIONS; RECEPTOR ACTIVATOR; SEX STEROIDS; T LYMPHOCYTES;

GYNECOLOGY; LIGANDS; MAMMALS;

BONE;

ESTROGEN; OSTEOCLAST DIFFERENTIATION FACTOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MASS; BONE REMODELING; CANCELLOUS BONE; CELL COUNT; CONTROLLED STUDY; CORTICAL BONE; ESTROGEN DEFICIENCY; FEMALE; GENE DELETION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; T LYMPHOCYTE;

ALLELES; ANIMALS; B-LYMPHOCYTES; BONE DENSITY; BONE REMODELING; ESTROGENS; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; OSTEOCLASTS; OSTEOPOROSIS; OVARIECTOMY; RANK LIGAND; T-LYMPHOCYTES;

MUS;

EID: 84865446399     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.377945     Document Type: Article

References (53)

1. Manolagas, S. C. (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21, 115-137
2. Di Gregorio, G. B., Yamamoto, M., Ali, A. A., Abe, E., Roberson, P., Manolagas, S. C., and Jilka, R. L. (2001) Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17β-estradiol. J. Clin. Invest. 107, 803-812
3. Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., and Costantini, F. (1994) Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13, 1189-1196
4. Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., and Manolagas, S. C. (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 257, 88-91
5. Ammann, P., Rizzoli, R., Bonjour, J. P., Bourrin, S., Meyer, J. M., Vassalli, P., and Garcia, I. (1997) Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J. Clin. Invest. 99, 1699-1703
6. Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., and Pacifici, R. (1995) Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136, 3054-3061
7. Lorenzo, J. A., Naprta, A., Rao, Y., Alander, C., Glaccum, M., Widmer, M., Gronowicz, G., Kalinowski, J., and Pilbeam, C. C. (1998) Mice lacking the type I interleukin-1 receptor do not lose bone mass after ovariectomy. Endocrinology 139, 3022-3025
8. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P., and Kato, S. (2007) Estrogen prevents bone loss via estrogen receptor α and induction of Fas ligand in osteoclasts. Cell 130, 811-823
9. Martin-Millan, M., Almeida, M., Ambrogini, E., Han, L., Zhao, H., Weinstein, R. S., Jilka, R. L., O'Brien, C. A., and Manolagas, S. C. (2010) The estrogen receptor-α in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol. Endocrinol. 24, 323-334
10. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W. J. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176
11. Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C. R., Lacey, D. L., Mak, T. W., Boyle, W. J., and Penninger, J. M. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323
12. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H. L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T. M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R., and Boyle, W. J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319
13. Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., Boyle, W. J., and Simonet, W. S. (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12, 1260-1268
14. Horowitz, M. C., Fretz, J. A., and Lorenzo, J. A. (2010) How B cells influence bone biology in health and disease. Bone 47, 472-479
15. Pacifici, R. (2012) Role of T cells in ovariectomy-induced bone loss-revisited. J. Bone Miner. Res. 27, 231-239
16. Kanematsu, M., Sato, T., Takai, H., Watanabe, K., Ikeda, K., and Yamada, Y. (2000) Prostaglandin E-2 induces expression of receptor activator of nuclear factor-κB ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J. Bone Miner. Res. 15, 1321-1329
17. Li, X., Ominsky, M. S., Stolina, M., Warmington, K. S., Geng, Z., Niu, Q. T., Asuncion, F. J., Tan, H. L., Grisanti, M., Dwyer, D., Adamu, S., Ke, H. Z., Simonet, W. S., and Kostenuik, P. J. (2009) Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin. Bone 45, 669-676
18. Proell, V., Xu, H., Schüler, C., Weber, K., Hofbauer, L. C., and Erben, R. G. (2009) Orchiectomy up-regulates free soluble RANKL in bone marrow of aged rats. Bone 45, 677-681
19. Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., and Riggs, B. L. (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J. Clin. Invest. 111, 1221-1230
20. Taxel, P., Kaneko, H., Lee, S. K., Aguila, H. L., Raisz, L. G., and Lorenzo, J. A. (2008) Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study. Osteoporos. Int. 19, 193-199
21. Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., and O'Brien, C. A. (2011) Matrix-embedded cells control osteoclast formation. Nat. Med. 17, 1235-1241
22. O'Brien, C. A., Jilka, R. L., Fu, Q., Stewart, S., Weinstein, R. S., and Manolagas, S. C. (2005) IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am. J. Physiol. Endocrinol. Metab. 289, E784-793
23. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25, 402-408
24. Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., and Recker, R. R. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610
25. Rickert, R. C., Roes, J., and Rajewsky, K. (1997) B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25, 1317-1318
26. Masuzawa, T., Miyaura, C., Onoe, Y., Kusano, K., Ohta, H., Nozawa, S., and Suda, T. (1994) Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J. Clin. Invest. 94, 1090-1097
27. Kincade, P. W., Medina, K. L., and Smithson, G. (1994) Sex hormones as negative regulators of lymphopoiesis. Immunol. Rev. 137, 119-134
28. Hennet, T., Hagen, F. K., Tabak, L. A., and Marth, J. D. (1995) T-cell-specific deletion of a polypeptideN-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc. Natl. Acad. Sci. U.S.A. 92, 12070-12074
29. Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., Penninger, J. M., and Takayanagi, H. (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231-1234
30. Miyaura, C., Onoe, Y., Inada, M., Maki, K., Ikuta, K., Ito, M., and Suda, T. (1997) Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc. Natl. Acad. Sci. U.S.A. 94, 9360-9365
31. Ishimi, Y., Miyaura, C., Ohmura, M., Onoe, Y., Sato, T., Uchiyama, Y., Ito, M., Wang, X., Suda, T., and Ikegami, S. (1999) Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology 140, 1893-1900
32. Onoe, Y., Miyaura, C., Ito, M., Ohta, H., Nozawa, S., and Suda, T. (2000) Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J. Bone Miner. Res. 15, 541-549
33. +CD28 null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS One 6, e21216
34. Lee, S. K., Kalinowski, J. F., Jacquin, C., Adams, D. J., Gronowicz, G., and Lorenzo, J. A. (2006) Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss. J. Bone Miner. Res. 21, 695-702
35. Manabe, N., Kawaguchi, H., Chikuda, H., Miyaura, C., Inada, M., Nagai, R., Nabeshima, Y., Nakamura, K., Sinclair, A. M., Scheuermann, R. H., and Kuro-o, M. (2001) Connection between B lymphocyte and osteoclast differentiation pathways. J. Immunol. 167, 2625-2631
36. + T cells. Eur. J. Immunol. 31, 2179-2188
37. Han, X., Kawai, T., Eastcott, J. W., and Taubman, M. A. (2006) Bacterial-responsive B lymphocytes induce periodontal bone resorption. J. Immunol. 176, 625-631
38. Farrugia, A. N., Atkins, G. J., To, L. B., Pan, B., Horvath, N., Kostakis, P., Findlay, D. M., Bardy, P., and Zannettino, A. C. (2003) Receptor activator of nuclear factor-κB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo. Cancer Res. 63, 5438-5445
39. Heider, U., Zavrski, I., Jakob, C., Bängeroth, K., Fleissner, C., Langelotz, C., Possinger, K., Hofbauer, L. C., Viereck, V., and Sezer, O. (2004) Expression of receptor activator of NF-κB ligand (RANKL) mRNA in human multiple myeloma cells. J. Cancer Res. Clin. Oncol. 130, 469-474
40. Li, Y., Li, A., Yang, X., and Weitzmann, M. N. (2007) Ovariectomy-induced bone loss occurs independently of B cells. J. Cell. Biochem. 100, 1370-1375
41. Li, Y., Toraldo, G., Li, A., Yang, X., Zhang, H., Qian, W. P., and Weitzmann, M. N. (2007) B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo. Blood 109, 3839-3848
42. + cells: its role in accelerated osteoclastogenesis because of estrogen deficiency. J. Bone Miner. Res. 16, 2215-2221
43. Katavi, V., Grcevi, D., Lee, S. K., Kalinowski, J., Jastrzebski, S., Dougall, W., Anderson, D., Puddington, L., Aguila, H. L., and Lorenzo, J. A. (2003) The surface antigen CD45R identifies a population of estrogen-regulated murine marrow cells that contain osteoclast precursors. Bone 32, 581-590
44. Blin-Wakkach, C., Wakkach, A., Rochet, N., and Carle, G. F. (2004) Characterization of a novel bipotent hematopoietic progenitor population in normal and osteopetrotic mice. J. Bone Miner. Res. 19, 1137-1143
45. Pugliese, L. S., Gonçalves, T. O., Popi, A. F., Mariano, M., Pesquero, J. B., and Lopes, J. D. (2012) B-1 lymphocytes differentiate into functional osteoclast-like cells. Immunobiology 217, 336-344
46. Jacquin, C., Gran, D. E., Lee, S. K., Lorenzo, J. A., and Aguila, H. L. (2006) Identification of multiple osteoclast precursor populations in murine bone marrow. J. Bone Miner. Res. 21, 67-77
47. Jilka, R. L. (1998) Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. Bone 23, 75-81
48. Perlot, T., and Penninger, J. M. (2012) Development and function of murine B cells lacking RANK. J. Immunol. 188, 1201-1205
49. Hobeika, E., Thiemann, S., Storch, B., Jumaa, H., Nielsen, P. J., Pelanda, R., and Reth, M. (2006) Testing gene function early in the B cell lineage in mb1-Cre mice. Proc. Natl. Acad. Sci. U.S.A. 103, 13789-13794
50. Lee, S. K., Kadono, Y., Okada, F., Jacquin, C., Koczon-Jaremko, B., Gronowicz, G., Adams, D. J., Aguila, H. L., Choi, Y., and Lorenzo, J. A. (2006) T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J. Bone Miner. Res. 21, 1704-1712
51. Li, J. Y., Tawfeek, H., Bedi, B., Yang, X., Adams, J., Gao, K. Y., Zayzafoon, M., Weitzmann, M. N., and Pacifici, R. (2011) Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc. Natl. Acad. Sci. U.S.A. 108, 768-773
52. D'Amelio, P., Grimaldi, A., Di Bella, S., Brianza, S. Z., Cristofaro, M. A., Tamone, C., Giribaldi, G., Ulliers, D., Pescarmona, G. P., and Isaia, G. (2008) Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 43, 92-100
53. Ikeda, T., Utsuyama, M., and Hirokawa, K. (2001) Expression profiles of receptor activator of nuclear factor κB ligand, receptor activator of nuclear factor κB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones. J. Bone Miner. Res. 16, 1416-1425